Hospital
ST Davids Healthcare Partnership LP LLP
ST Davids Healthcare Partnership LP LLP was paid $15.67M by Medicaid between Oct 2020 and Dec 2024, across 74 billing codes. Its largest line is 99283, emergency room visit (moderate) — 31% of everything it billed.
33Billing provider infoST DAVIDS HEALTHCARE PARTNERSHIP LP LLP
AUSTIN, TX 78758
AUSTIN, TX 78758
33aNPI1629021845assigned 05/18/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$15.67M
24GClaims172,173
24DCodes billed74
24AFirst – last monthOct 2020 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Texas
Rank by total paid#6 of 109
Median peer was paid$1.15M
This provider vs. median14×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 2,154 | $248K | |
| 2021 | 39,474 | $3.34M | |
| 2022 | 58,008 | $4.92M | |
| 2023 | 50,983 | $5.08M | |
| 2024incomplete | 21,554 | $2.08M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 31% | 36,088 | 35,365 | $4.81M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 30% | 13,659 | 13,104 | $4.76M |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 12% | 13,528 | 9,140 | $1.94M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 11% | 12,735 | 12,538 | $1.71M |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 3.2% | 1,958 | 1,916 | $507K |
| 76819 | Fetal biophysical profile; without non-stress testing | 2.5% | 5,335 | 2,731 | $399K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.6% | 1,765 | 1,748 | $244K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 1.2% | 1,406 | 1,344 | $190K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1.0% | 1,878 | 1,633 | $161K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 8,299 | 6,146 | $108K |
| 87400 | <1% | 6,436 | 6,276 | $92K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 5,203 | 5,125 | $72K |
62 more codes
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 325 | $62K |
| 85027 | <1% | 11,711 | $52K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 2,588 | $50K |
| 87486 | <1% | 1,959 | $44K | |
| 87581 | <1% | 1,958 | $44K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,959 | $42K |
| 87430 | <1% | 3,559 | $34K | |
| 76825 | <1% | 145 | $34K | |
| 80053 | Comprehensive metabolic panel | <1% | 4,205 | $31K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,335 | $29K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,898 | $26K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,258 | $24K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,355 | $22K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,117 | $21K |
| 87070 | <1% | 2,385 | $18K | |
| 81001 | <1% | 7,390 | $18K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,730 | $13K |
| 99285 | Emergency room visit (most serious) | <1% | 179 | $13K |
| 76801 | <1% | 106 | $11K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,117 | $9K |
| 76821 | <1% | 128 | $9K | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,052 | $8K |
| 76820 | <1% | 119 | $7K | |
| 93325 | <1% | 144 | $6K | |
| 93976 | <1% | 58 | $6K | |
| 94644 | <1% | 80 | $5K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 164 | $4K |
| 81025 | <1% | 960 | $4K | |
| 87420 | <1% | 474 | $4K | |
| 76827 | <1% | 40 | $3K | |
| 84702 | <1% | 220 | $3K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 826 | $3K |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 587 | $2K |
| 83690 | <1% | 907 | $2K | |
| 84484 | <1% | 988 | $2K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 12 | $1K |
| 86141 | <1% | 189 | $1K | |
| 74018 | <1% | 26 | $447.76 | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 20 | $443.13 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 54 | $432.99 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 17 | $313.20 |
| 86901 | <1% | 201 | $308.73 | |
| 86900 | <1% | 201 | $308.73 | |
| 84703 | <1% | 73 | $283.61 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,527 | $260.85 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 144 | $235.53 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 128 | $170.01 |
| 83735 | <1% | 73 | $99.81 | |
| 87186 | <1% | 14 | $46.99 | |
| 82248 | <1% | 28 | $21.92 | |
| 85610 | <1% | 100 | $21.60 | |
| 85730 | <1% | 31 | $20.20 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 56 | $9.85 |
| 84100 | <1% | 17 | $5.39 | |
| A9270 | Non-covered item or service | 0% | 2,551 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 26 | $0.00 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 0% | 79 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 19 | $0.00 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 0% | 18 | $0.00 |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 0% | 13 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 66 | $0.00 |
| G1003 | Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program | 0% | 174 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBAKER, JON (CFO)